Munich Cluster for Systems Neurology
print


Breadcrumb Navigation


Content

Frontiers of CardioVascular Biomedicine 2022 Budapest is on in person! The excellent program proves that scientists won against Covid-19.

Cardiovasc Res. 2022 Apr 19:cvac064. doi: 10.1093/cvr/cvac064. Epub ahead of print. PMID: 35438746.

Authors/Editors: Ferdinandy P, Koller Á, Weber C, Wojta J, Waltenberger J.
Publication Date: 2022

Abstract

Frontiers in Cardiovascular Biomedicine (FCVB, previously called Frontiers in Cardiovascular Biology) is the main biennial congress of the Council on Basic Cardiovascular Science (CBCS) of the European Society of Cardiology (ESC). By now, FCVB meetings are considered as one of the most relevant exchange platforms for basic and translational cardiovascular biomedicine in Europe and beyond. The change from the previous word in the name of the congress from ‘biology’ to ‘biomedicine’ is intended to emphasize the focus of FCVB meetings to facilitate the translation of laboratory findings into clinical medicine. FCVB is a widely inclusive congress in collaboration with several scientific cardiovascular sister societies and societies world-wide.

The upcoming 6th FCVB Congress had been originally planned to be held in 2020 in Budapest, Hungary. However, after years of planning it had to be postponed due to the rapid spread of the new SARS-COV-2 virus-induced disease, COVID-19. But finally, the pandemic dramatically subsided—at least in Europe—thus the congress will take place in-person on 29 April to 1 May 2022! Yes, as they say in Broadway, the show must go on!

There was again a careful selection of a comprehensive scientific programme and as a result about 400 participants are expected to come to Budapest from all over the world, plus industry representatives and likely family members.

Again, ESC leaders and the FCVB core committee including the local organizers carefully followed and evaluated the COVID-19 situation, and because in Europe the disease substantially subsided and the safety measures are lifted, it allowed us the make this congress happen this April. The Semmelweis University premises (including the venue of the meeting, the Basic Medical Science Center) has been also opened for students, faculty and employees in 2022. Nevertheless, we are proceeding with precaution and extra hygiene conditions.

We know that these 2 years were hard on everyone and had serious impact on scientific and personal life, but perhaps that is a main reason to get together and put our personality in the meeting, renew friendship, and make new connections. Most of all for young people it is essential to move out ‘from the home office’ and meet each other and establish friendship which can last for a life time.

The Scientific Programme Chairs, Prof. Péter Ferdinandy and Prof. Ákos Koller, and Prof. Béla Merkely, rector of Semmelweis University, are delighted to welcome you to Budapest to the sixth edition of FCVB.

In the inaugural session, the welcome speech of the vice-rector of Semmelweis University will pay a special tribute to Ignác Semmelweis, a Hungarian physician, who discovered the cause of puerperal (childbed) fever and introduced antisepsis into medical practice. He is considered to be the father of hygiene, being the first person who introduced handwashing of doctors, which prevented the spread of puerperal disease, and the death of thousands of mothers in the late nineteenth century. Unfortunately, the hygiene became an actuality today, at the time of the devastating COVID-19 pandemic. Because he was the head of the Gynecology Clinic, later the University assumed his name: Semmelweis University, which celebrated its 250 years of anniversary in 2020, the original date of the meeting.

The aim of FCVB 2022 is to provide a very wide spectrum of presentations on novel basic science discoveries and the latest developments in new therapies related to cardiac and vascular diseases. The scientific programme has been devised in collaboration with the 14 ESC Working Groups and Sister Societies involved to cover the most exciting new findings and to facilitate the exploration of novel areas. We have a broad range of Keynote Lectures and symposia from molecular networks of the cardiovascular diseaseome, to mechanisms linking atrial fibrillation and stroke, extracellular vesicles, novel RNA therapies, network medicine and big data, and the mechanisms of drug cardiotoxicity, including hidden cardiotoxicity. Moreover, the programme committee included a session focusing on the cardiovascular effects of COVID-19.

Pushing the frontiers even further, we have two Late Breaking Science Poster sessions covering an interesting array of novel research ideas, including new biomarkers, new risk scores and new approaches to help address unanswered questions in cardiovascular biomedicine. The CBCS is proud to support our young talent and we will have two Young Investigator Award (YIA) sessions to showcase their research, with an acknowledgement to the winners at the Awards and Closing Ceremony on the last day. A Semmelweis Best Poster Award will be given for the best young presenters as well.

The place to be for the young and senior investigators to mingle in: the Moderated Poster Sessions, providing an essential part of the meeting, where you can build your scientific and friendship network at the posters in addition to the social programmes. We not just hope but know that you will enjoy your trip to Hungary and explore the touristic and cultural treasures of Budapest! So please join us and help to make FCVB 2022 the major international congress for basic and translational cardiovascular biomedicine and to show that pandemic or other difficulties can be overcome and scientists have their share to do so!

 

Related Links